Evidence map›Paper›PMID 21037095›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

IL-2 complex treatment can protect naive mice from bacterial and viral infection.

Sara E Hamilton, Jason M Schenkel, Adovi D Akue, Stephen C Jameson

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. IL-2 and Beyond in Cancer Immunotherapy.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2018
    Review
  10. Article
  11. IL-2 complex treatment amplifies CD8Microbes and infection · 2016
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sara E HamiltonDepartment of Laboratory Medicine and Pathology, University of Minnesota Medical Center, Center for Immunology, Minneapolis, MN 55454, USA. hamil062@umn.edu
Jason M Schenkel
Adovi D Akue
Stephen C Jameson

Funding

TRAINING GRANT IN MICROBIOLOGY/CANCER RESEARCHT32CA009138 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Scott M. Dehm · 1985 to 2026
$11.3M
IMMUNOLOGY TRAINING PROGRAMT32AI007313 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Carla Rothlin · 1989 to 2026
$5.7M
Homeostatic Proliferation and Memory CD8 T CellsR01AI075168 · NIAID · UNIVERSITY OF MINNESOTA · PI JAMESON, STEPHEN C · 2008 to 2016
$3.1M
Homeostatic Proliferation and Memory CD8 T CellsR56AI075168 · NIAID · UNIVERSITY OF MINNESOTA · PI JAMESON, STEPHEN C · 2007 to 2007
$371k
NCI NIH HHS T32 CA009138NIAID NIH HHS AI075168NIAID NIH HHS R01 AI075168NIAID NIH HHS R56 AI075168NIAID NIH HHS T32 AI007313NIAID NIH HHS T32 AI07313
6 · The paper itself

Abstract

IL-2 complexes have substantial effects on the cellular immune system, and this approach is being explored for therapeutic application in infection and cancer. However, the impact of such treatments on subsequent encounter with pathogens has not been investigated. In this study, we report that naive mice treated with a short course of IL-2 complexes show enhanced protection from newly encountered bacterial and viral infections. IL-2 complex treatment expands both the NK and CD8 memory cell pool, including a recently described population of preexisting memory-phenotype T cells responsive to previously unencountered foreign Ags. Surprisingly, prolonged IL-2 complex treatment decreased CD8 T cell function and protective immunity. These data reveal the impact of cytokine complex treatment on the primary response to infection.

Indexed as

AgingAnimalsCD8-Positive T-LymphocytesCell ProliferationFemaleGene Expression RegulationGranzymesImmunologic MemoryImmunophenotypingInterferon-gammaInterleukin-2ListeriosisMiceMice, Inbred C57BLVacciniaGranzymesGzmb protein, mouseInterferon-gammaInterleukin-2

Identifiers

PMID21037095
PMCPMC3016939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.